Cancer Survivorship Research, Practice and Policy
Deadline for manuscript submissions: closed (1 March 2022) | Viewed by 22518
2. Cancer Control Research, BC Cancer, Vancouver, BC V5Z 1L3, Canada
3. Canadian Centre for Applied Research in Cancer Control (ARCC), Vancouver, BC V5Z 1L3, Canada
Interests: cancer survivorship; health economics; quality of life; priority setting; public engagement
The number of new cancer cases diagnosed each year is rising across the globe, largely as a result of growing and ageing populations. That said, due to advances in early detection, therapeutics, and cancer staging, survivorship rates have increased substantially over the past five decades. In high-income countries, almost two-thirds of cancer survivors now survive more than five years after their cancer diagnosis. Yet, many survivors live with complex physical, psychosocial, and financial impacts of their diagnosis long after treatment completion. Supporting survivors through these lifelong challenges requires a care delivery system that is effective, person- and family-centred, and sustainable, so individuals and their families not only survive cancer but flourish.
In the past three decades, cancer survivorship research has emerged as a distinct and highly interdisciplinary field. The purpose of this Special Issue is to provide a forum for new research articles, evidence reviews, expert perspectives, and novel ideas on a breadth of topics related to cancer survivorship research, practice and policy.
Examples of submissions include (but are not limited to):
- Epidemiological and descriptive studies on the incidence and prevalence of adverse and/or late-effects, including physical, psychological, and social problems
- Interventional and implementation studies addressing health and social problems relating to adverse and/or late effects
- Health services and policy-related research, including cost-effectiveness analyses of cancer survivorship practice and policies
- Methodological and measurement studies in cancer survivorship
Topics may include (but are not limited to): rehabilitation, exercise, health-related behaviors, virtual health, health equity, pandemic preparedness, return to work, quality of care, models of care, quality of life, cognitive dysfunction, sexual problems, fertility, and mental health.
Prof. Dr. Stuart Peacock
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cancer survivor
- late effects
- models of care
- supportive care
- care plan